Philips Foundation Impact Investments

What Philips Foundation Impact Investments does

Philips Foundation Impact Investments is the impact investment arm of Philips Foundation, a Dutch-registered non-profit organization (ANBI status) established in 2014 and funded by Royal Philips. Operating through a wholly-owned subsidiary (Philips Foundation Impact Investments B.V., established 2021), it deploys grants, catalytic capital, and co-investments to strengthen healthcare systems in underserved communities, with thematic focus on cardiovascular disease and maternal/child health. As of 2025 the foundation manages 44 active grant-based projects and a portfolio of 14 impact investments, and in 2025 mobilized EUR 31.2 million in co-investments alongside its programs, reaching 69 million people with healthcare access (up from the prior year) and targeting 100 million annually by 2030.

The foundation's "continuum-of-capital" model combines grant funding to test and validate healthcare solutions with impact investments to scale proven ones, supported by an in-kind contribution from Royal Philips (volunteers, products, services, office space). Its proprietary frameworks include the Chain of Care approach (end-to-end cardiovascular care pathway from prevention to long-term management) and the ImpactBridge co-investment platform launched in 2025 with World Diabetes Foundation and We Share Forward Foundation. Portfolio companies operate point-of-care diagnostic tools, AI-assisted radiology and screening, mobile health platforms, electronic health records (AfyaPro), and consumer-facing apps (28X menstrual tracking, Helpfie emergency aid). Technology stack includes portable ultrasound, handheld ECG, digital stethoscopes, AI-assisted radiology reporting (Rology), AI-based breast cancer screening (Mamotest), and Android-based mHealth tools for pneumonia case management (ChARM + ZMQ). Geographic footprint spans the Netherlands (HQ), with active programs across Europe (UK, Ireland, Italy, Ukraine), Middle East & Africa (Kenya, Tanzania, Uganda, Malawi, Rwanda), Asia Pacific (India, Bangladesh, Indonesia, Philippines, China), Latin America (Brazil, Argentina, Peru), and the United States.

The organization is not a commercial enterprise: it does not sell products or services. Its economic engine is philanthropic capital allocation — annual funding from Royal Philips, in-kind contributions, and co-investment mobilized from third-party partners (e.g., Novartis Foundation, BRAC, World Heart Federation, MIT Solve, World Diabetes Foundation). The foundation earns no revenue in the conventional sense; "throughput" is measured in capital deployed, projects managed, and beneficiaries reached. Customer relationships are grant agreements with NGOs and impact investments in mission-driven healthcare ventures, while end beneficiaries are underserved populations globally.

Name

Philips Foundation Impact Investments

Legal name

Philips Foundation

Website

https://philips-foundation.com

Company type

Private

Founded year

2014

Operating status

Operating

Short description

Philips Foundation Impact Investments is a Dutch non-profit impact investor (backed by Royal Philips) that deploys grants and catalytic capital to strengthen healthcare systems for underserved communities, focusing on cardiovascular disease and maternal/child health through a portfolio of 14 ventures and 44 active projects.

Ownership category

akta.pro rank

Product category

Healthcare Impact Investing

NAICS

Scientific Research and Development Services (5417)

SIC

International Affairs (9721)

akta.pro primary industry

Healthcare Access & Life Sciences Impact Funds (FSANAJAI)

akta.pro secondary industries

Impact / ESG Venture Capital (FSANAAAG), Impact Investing & Social Finance (Funds, CDFIs, Microfinance) (BPAGALAA), Impact Investing (Intentional, Measurable Social/Environmental Outcomes) (FSAAALAC)

Keywords

• Impact investing
• Venture philanthropy
• Healthcare grants
• Social enterprise funding
• Catalytic capital

Headquarters

HQ city

Nieuw-amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Technology or R&D, Marketing or Sales

Revenue model

1. Grant-based funding: Philips Foundation receives annual funding from Royal Philips and deploys grants to test and validate healthcare solutions in underserved settings. The foundation also receives in-kind funding through expert volunteers, products, services, office space, IT and travel support.
2. Impact Investments: Through its subsidiary Philips Foundation Impact Investments B.V., the foundation makes social impact investments in mission-driven ventures that demonstrate operational readiness, financial sustainability, and system integration capability. Investments are designed to support ventures at stages where catalytic capital can unlock sustainable growth.
3. Co-investment Mobilization: Philips Foundation mobilizes co-investment from partners to scale proven healthcare solutions. In 2025, mobilized EUR 31.2 million in co-investments. Also launched ImpactBridge co-investment platform with World Diabetes Foundation and We Share Forward Foundation.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Core offering

Philips Foundation Impact Investments B.V. is a non-profit impact investment subsidiary of Philips Foundation that deploys catalytic capital — grants, co-investments and equity investments — into 14 mission-driven healthcare ventures. It strengthens healthcare systems in underserved communities through a continuum-of-capital model, focusing on cardiovascular disease and maternal and child health, while operating the ImpactBridge co-investment platform and the Knowledge Hub.

Product overview

Philips Foundation Impact Investments operates a portfolio of 14 social ventures (as of 2025) focused on strengthening healthcare systems in underserved communities. The portfolio includes: (1) Diagnostic solutions such as iMedrix (mobile cardiology), Rology (AI-assisted teleradiology), Mamotest (AI-powered oncologic screening), and Briota (NCD screening); (2) Healthcare delivery platforms including Access Afya, Ilara Health, iKure, and Last Mile Care; (3) Monitoring devices like ChARM (pneumonia detection) and GOAL 3 (affordable monitoring systems); (4) Consumer-facing apps including 28X (period tracking), Helpfie (emergency aid), and CheckUps (medication delivery); (5) AI-powered health services such as Diagnostikare for Latin American communities; and (6) Supporting infrastructure like Solvoz (procurement) and Healthy Entrepreneurs (distribution). The foundation also operates a Knowledge Hub for sharing learnings. Investments are executed through Philips Foundation Impact Investments B.V., supporting ventures in cardiovascular disease and maternal and child health using a continuum-of-capital model from grants to impact investments.

Differentiator

Problem solved

Functional benefit

Brands

• Philips Foundation Impact Investments: Social impact investment subsidiary that deploys catalytic capital to help proven healthcare solutions expand sustainably
• ImpactBridge

Products and services

• Grant-Based Projects Program
• Impact Investment Portfolio
• ImpactBridge Co-Investment Platform
• Knowledge Hub
• CARDIO4Cities Cardiovascular Health Program
• MIT Solve Social Impact Award

Quantifiable outcome

• 69 million people gained access to healthcare in 2025
• +5 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

25 partnerships are on record, tiered flagship and core.

• Novartis FoundationflagshipStrategic or Co-development Partner · 21 May 2026Global partnership to expand the CARDIO4Cities approach - a comprehensive data-driven approach to improve cardiovascular health and health equity across cities. Initial focus on Amsterdam with potential expansion to other urban regions. Combines Novartis Foundation's experience in data-driven city interventions with Philips Foundation's ability to deploy innovative health technologies.
• MIT SolvecoreGTM or Marketing Partner · 24 April 2026Collaboration for Social Impact Award, inviting global innovators to scale healthcare solutions with $100,000 prize, mentorship, and network access.
• World Child CancercoreStrategic or Co-development Partner · 22 April 2025Partnership to drive early childhood cancer detection in Indonesia, improving outcomes for children with cancer in underserved communities.
• SAS BrasilcoreStrategic or Co-development Partner · 1 July 2024Partnership to launch an innovation lab to drive digital health solutions in Brazil, focusing on bringing healthcare innovation to underserved communities in Latin America.
• Stichting GelijkGezondcoreStrategic or Co-development Partner · 3 May 2024Partnership to reduce health disparities in the Netherlands, addressing health inequities within the Dutch healthcare system.
• March of DimescoreStrategic or Co-development Partner · 4 April 2024Partnership to improve prenatal care access, focusing on supporting mothers and babies before, during, and after pregnancy in the United States.
• Mercy ShipscoreStrategic or Co-development Partner · 17 October 2023Partnership to improve access to healthcare through Mercy Ships' hospital ships providing surgical care and training in West Africa.
• RAD-AIDcoreStrategic or Co-development Partner · 13 September 2022Multi-year partnership to increase access to ultrasound services for 50 million people through technology deployment and training programs.
• BRACcoreStrategic or Co-development PartnerPartnership to strengthen maternal and child health services in hard-to-reach island communities in Bangladesh. Establishes fully functional health facilities and expands community outreach to improve coverage of antenatal care including early screening and high-risk pregnancy identification.
• World Heart FederationcoreStrategic or Co-development PartnerPartnership to bring cardiovascular screening closer to communities in Philippines and Indonesia. School-based screening programs and primary care initiatives using portable ultrasound and trained health workers to detect early signs of rheumatic heart disease.
• Global Action PlancoreStrategic or Co-development PartnerPartnership for Clean Air for Schools Program in UK and Ireland. Primary research on impact of polluted air on children's health and development of Clean Air for Schools Framework.
• University of ManchestercoreTechnology or IntegrationAcademic partnership conducting primary research on air pollution impact on children's health and learning ability in UK schools as part of Clean Air for Schools Program.
• Save the Children IndiacoreStrategic or Co-development PartnerVISHWAAS project collaboration to develop and prove low-cost innovative approaches for prevention, diagnosis, and management of childhood pneumonia in India using mHealth applications and ChARM diagnostic tools.
• ZMQ DevelopmentcoreTechnology or IntegrationSocial enterprise developing Android-based mHealth pneumonia tools including social behavior change communication apps and case management toolkits for frontline health workers in India.
• Imaging the WorldcoreStrategic or Co-development PartnerPartnership to make ultrasound accessible at point of care in East Africa. Dedicated training programs and specialized facility in Kampala equipping midwives to perform basic obstetric ultrasound.
• AfyaProcoreTechnology or IntegrationElectronic health record system provider for digitization of primary health facilities in Kenya, integrated with Philips maternal obstetric monitoring solutions for continuous improvement cycles.
• 28XcoreStrategic or Co-development PartnerMenstrual cycle tracking tool invested through Philips Foundation Impact Investments. Privacy-first platform designed to work in real-world conditions for women often left behind by traditional health innovation.
• Access AfyacoreStrategic or Co-development PartnerHealthcare operating system for emerging economies creating high-quality, localized healthcare for low- and middle-income markets in Kenya.
• Ilara HealthcoreStrategic or Co-development PartnerEnables small clinics in Africa with diagnostics and funding for quality, affordable healthcare for underserved communities.
• iKurecoreStrategic or Co-development PartnerHub-and-spoke model for rural health in India, delivering affordable quality healthcare through technology, community-based care, and data-driven systems.
• RologycoreTechnology or IntegrationAI-assisted teleradiology platform providing immediate global access to top-tier radiological expertise for every patient, addressing diagnostic bottlenecks in underserved settings.
• MamotestcoreStrategic or Co-development PartnerAI-based solution democratizing access to breast cancer screening and diagnosis in Latin America, providing efficient path to treatment.
• GOAL 3coreStrategic or Co-development PartnerAffordable monitoring systems enabling health workers with durable, easy-to-use medical technology at point of care, deployed in Malawi and Rwanda.
• Ambrosoli FoundationcoreStrategic or Co-development PartnerPartnership since 2024 in Uganda strengthening early maternal health care through community education and high-risk pregnancy tools.
• National Institute for Medical Research (Tanzania)coreStrategic or Co-development PartnerReferral model project connecting one central hospital with 15 spoke hospitals through structured referral system using AI-supported ECG interpretation.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Acumen: Pioneer impact-investment fund focused on healthcare, energy and agriculture for low-income communities; comparable as a foundation that combines grants and equity investments to scale patient-serving enterprises in LMICs.
• Bayer Foundation: Corporate foundation of a life-science company funding health access, women empowerment and social innovation in LMICs via grants and impact investments; near-twin structure to Philips Foundation.
• Merck Foundation: Pharma company's corporate foundation funding healthcare capacity building, oncology and maternal health in underserved countries; directly comparable structure to Philips Foundation's corporate-funded impact model.
• Children's Investment Fund Foundation (CIFF): Major philanthropic impact investor active in maternal/child health and cardiovascular health globally; deploys catalytic capital and program-related investments in LMICs with a comparable continuum-of-capital philosophy.
• Novartis Foundation: Pharma corporate foundation focused on digital health, NCDs and health-system strengthening, co-running CARDIO4Cities with Philips Foundation. Directly comparable as a corporate-backed impact investor in cardiovascular and global health.
• UBS Optimus Foundation: Corporate-backed philanthropic foundation running health and education impact-investment programs in emerging markets; comparable as a company-linked foundation deploying catalytic capital alongside grants.

Others

• PATH: Global health non-profit that co-designs, funds and scales health-system and medical-innovation projects in LMICs; comparable as an ecosystem partner operating in the same cardiovascular, maternal, and child-health verticals but not a direct investor.

Broad incumbents

• Bill & Melinda Gates Foundation: World's largest philanthropic funder of global health equity and innovation. Operates in adjacent disease areas (maternal/child health, NCDs) with grant and program-related investment models, though at vastly greater scale.
• Wellcome Trust: Large independent health-research foundation funding infectious disease, mental health and climate-health programs globally; overlapping focus areas but structured around research grants rather than impact investing.

Emerging players

• WHO Foundation: Newer global health-financing entity mobilizing philanthropic and corporate capital for WHO priorities; comparable mission of resource mobilization for health-systems strengthening but less established as a direct investor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/philipsfdn
• Facebookfacebook.com/PhilipsFoundation

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Philips Foundation Impact Investments